OVERVIEW

Fetal and neonatal alloimmune thrombocytopenia (FNAIT) can lead to substantial medical challenges for the mother, fetus, and neonate. Diagnosis is often difficult without low platelet counts or frank bleeding. But a mother’s risk for FNAIT can be assessed, and existing and newly emerging therapies can act as preventive measures and improve fetus/neonate outcomes. Join Drs. Karin Blakemore and Emilie Vander Haar as they address many of the issues surrounding the management of FNAIT and offer clear and actionable suggestions for you to bring into your clinical practice.

KEY DATES

Registrations Open
19 Nov, 2026
Registrations Open
Event Start Date
31 Jan, 2025
Event Start Date
Event End Date
30 Apr, 2027
Event End Date
Credits

Global Learning Collaborative (GLC) designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Global Learning Collaborative (GLC) designates this activity for 1.0 nursing contact hour(s). Nurses should claim only the credit commensurate with the extent of their participation in the activity. Global Learning Collaborative (GLC) designates this activity for 1.0 contact hour(s)/0.1 CEUs of pharmacy contact hour(s).

AMA PRA Category 1: Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact Hours: Nurses should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™.

  • 1 AMA PRA Category 1
  • 1 Contact Hours
  • 1 AMA PRA Category 1
  • TARGET AUDIENCE

    PhysicianPharmacistNurse PractitionerPhysician AssistantPrimary Clinicians

    SPECIALITIES

    ObstetricsPrimary CareObstetrics and Gynecology

    RELATED CONFERENCES & LIVE WEBINARS